Myoderm expands its portfolio to include drug procurement, management and distribution services

Aug 25 2009

Myoderm, a leading global pharmaceutical supplier of comparator drugs for clinical research and clinical trials, has expanded its portfolio to include Distribution Management Services. This new capability provides their clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials. Distribution Management Services is an innovative, cost-saving alternative to the current approach of site or patient reimbursement of commercially sourced drugs.

Highlighting this new offering is a staff with extensive project management and logistics expertise, newly constructed state-of-the-art distribution facilities, and customized, proprietary technology to support clients' clinical supply planning, management, and sourcing.

Mike Cohen, Myoderm's Managing Director, foresees significant benefits for their clients: "With Distribution Management Services, our customers will be able to diminish logistical complexities, reduce exposure to waste, greatly improve traceability and control of their drug supplies, and more easily and cost-effectively achieve the time and cost benchmarks of their trials."